Hengrui Medicine (01276.HK): HRS-5635 Injection is included in the list of proposed breakthrough therapeutic products.

Wisdom Financial News APP reports that Hengrui Medicine (01276.HK) has announced that recently, its subsidiary Fujian Shengdi Pharmaceutical Co., Ltd.'s HRS-5635 injection has been included in the list of proposed breakthrough therapeutic drug varieties by the National Medical Products Administration Drug Evaluation Center, with a public notice period of 7 days.